Delving into the Latest Updates on Matrizyme Pharma Corp. with Synapse

概览

关联

1

项与 Matrizyme Pharma Corp. 相关的临床试验

NCT01753180 / Completed临床2期

A 2-stage Study to Evaluate Single Doses of MZ-004 at Different Dose Levels in Patients With Chronic Total Occlusions. Stage 1: Open Label Training Stage. Stage 2: Double-blind, Randomized, Placebo-Controlled Stage

A prospective, multi-center, double blind, 2 stage, placebo-controlled, phase II study, evaluating acute intra-coronary injected collagenase prior to routine standard-of-care percutaneous revascularization procedures in subjects with chronic total coronary artery occlusions (CTOs).

开始日期2014-04-01

申办/合作机构

Matrizyme Pharma Corp.

100 项与 Matrizyme Pharma Corp. 相关的临床结果

登录后查看更多信息

0 项与 Matrizyme Pharma Corp. 相关的专利（医药）

登录后查看更多信息

100 项与 Matrizyme Pharma Corp. 相关的药物交易

登录后查看更多信息

100 项与 Matrizyme Pharma Corp. 相关的转化医学

登录后查看更多信息